|
ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry ... - MarketWatch (press release) |
MarketWatch (press release)
SELZENTRY should not be used in patients with severe renal impairment or end-stage renal disease (ESRD) (CrCl <30 mL/min) who are taking potent CYP3A inhibitors or inducers. Hepatotoxicity accompanied by severe rash or systemic allergic reaction
|
|
Dialysis center open house is slated for today - Delmarva Now |
Delmarva Now
PRINCESS ANNE -- A kidney dialysis center that had been delayed from opening for the past four years because of a water shortage will open today with an open house and a visit from Lt. Gov. Anthony Brown and local elected officials. ...
Lieutenant Governor Brown Opens New Princess Anne Dialysis Center - Learns ... MarketWatch (press release)
Lt. Governor Brown Opens New Princess Anne Dialysis Center Business Wire (press release)
Possible Bearish Harami Candle Pattern Detected for Fresenius Medical Care
|
|
'Not a quiet disease': Orangeburg Kidney Walk set for Oct. 20 - The Times and Democrat |
The Times and Democrat
We really appreciate that from all of our walkers and sponsors, including Husqvarna, Palmetto Nephrology and Zeus." Higginbotham said it is very important that the NKFSC raise funds to support its patients and to prevent or delay kidney disease with
|
|
Therapeutic vaccines in renal cell carcinoma - Abstract - UroToday |
UroToday
Metastatic renal cell carcinoma (mRCC) is a lethal disease. The advent of tyrosine kinase inhibitors (TKIs) has changed the disease process, yet the majority of patients will develop treatment-resistant disease. IL-2 based immunotherapy in mRCC is the
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
